Literature DB >> 19407979

A simple HPLC method for doxorubicin in plasma and tissues of nude mice.

Ahmed M Al-Abd1, Nam Ho Kim, Soo-Chang Song, Seung Jin Lee, Hyo-Jeong Kuh.   

Abstract

Doxorubicin is a cytotoxic anthracycline that has been used for the treatment of several malignancies. Several HPLC methods have been reported for the quantification of doxorubicin in biological samples. Tissue matrix effect and sample size requirements, however, have been remaining issues for simple and easy-to-adapt analytical methods in small animal experiments. The present study established a simple HPLC method for doxorubicin in plasma and tissues (tumor, heart, spleen, liver, gastrointestinal tract, brain, lung, and kidney) of nude mice. Our method required a small sample volume (100 microL plasma and 10 mg tissue), which made it possible to use each blank tissue for calibration curves. The limit of quantification was 25 ng/mL in plasma and 0.1 to 0.4 microg/mg in other tissues with recovery rates ranging from 52.4 to 95.2%. The linearity, accuracy and precision in all tissues, except gastrointestinal tract (GIT), were found to be acceptable in the range of 25-2000 ng/mL plasma and 0.1-4 ng/mg tissue. This method was used successfully to determine the drug concentration in plasma and tissues of human tumor xenograft-bearing nude mice given intratumoral doxorubicin in a polymeric drug delivery system designed for sustained release. In conclusion, the present method may be useful as a simple and easy-to-adapt, yet, sensitive analytical method of doxorubicin for plasma and tissue pharmacokinetic studies in small animals such as nude mice.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19407979     DOI: 10.1007/s12272-009-1417-5

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  13 in total

1.  Intra-tumoral drug concentration mapping within solid tumor micro-milieu using in-vitro model and doxorubicin as a model drug.

Authors:  Ahmed M Al-Abd; Alaa Khedr; Salah G Atteiah; Fahad A Al-Abbasi
Journal:  Saudi Pharm J       Date:  2020-05-11       Impact factor: 4.330

2.  Curcumin nanoparticles inhibit corneal neovascularization.

Authors:  Nirparaj Pradhan; Rajdeep Guha; Sushovan Chowdhury; Sudip Nandi; Aditya Konar; Sarbani Hazra
Journal:  J Mol Med (Berl)       Date:  2015-04-17       Impact factor: 4.599

3.  Hyperthermia-enhanced targeted drug delivery using magnetic resonance-guided focussed ultrasound: a pre-clinical study in a genetic model of pancreatic cancer.

Authors:  Navid Farr; Yak-Nam Wang; Samantha D'Andrea; Frank Starr; Ari Partanen; Kayla M Gravelle; Jeannine S McCune; Linda J Risler; Stella G Whang; Amy Chang; Sunil R Hingorani; Donghoon Lee; Joo Ha Hwang
Journal:  Int J Hyperthermia       Date:  2017-07-17       Impact factor: 3.914

4.  Image-guided drug delivery with magnetic resonance guided high intensity focused ultrasound and temperature sensitive liposomes in a rabbit Vx2 tumor model.

Authors:  Ashish Ranjan; Genevieve C Jacobs; David L Woods; Ayele H Negussie; Ari Partanen; Pavel S Yarmolenko; Carmen E Gacchina; Karun V Sharma; Victor Frenkel; Bradford J Wood; Matthew R Dreher
Journal:  J Control Release       Date:  2011-12-21       Impact factor: 9.776

5.  Lyso-thermosensitive liposomal doxorubicin for treatment of bladder cancer.

Authors:  Andrew S Mikhail; Ayele H Negussie; William F Pritchard; Dieter Haemmerich; David Woods; Ivane Bakhutashvili; Juan Esparza-Trujillo; Sam J Brancato; John Karanian; Piyush K Agarwal; Bradford J Wood
Journal:  Int J Hyperthermia       Date:  2017-05-10       Impact factor: 3.914

6.  Exosome delivered anticancer drugs across the blood-brain barrier for brain cancer therapy in Danio rerio.

Authors:  Tianzhi Yang; Paige Martin; Brittany Fogarty; Alison Brown; Kayla Schurman; Roger Phipps; Viravuth P Yin; Paul Lockman; Shuhua Bai
Journal:  Pharm Res       Date:  2015-01-22       Impact factor: 4.200

7.  Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice.

Authors:  Rui Xue Zhang; Tian Zhang; King Chen; Ji Cheng; Paris Lai; Andrew M Rauth; K Sandy Pang; Xiao Yu Wu
Journal:  J Vis Exp       Date:  2017-10-05       Impact factor: 1.355

8.  A Simple and Sensitive HPLC Method for Fluorescence Quantitation of Doxorubicin in Micro-volume Plasma: Applications to Pharmacokinetic Studies in Rats.

Authors:  Marjan Daeihamed; Azadeh Haeri; Simin Dadashzadeh
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696

9.  Self-Triggered Apoptosis Enzyme Prodrug Therapy (STAEPT): Enhancing Targeted Therapies via Recurrent Bystander Killing Effect by Exploiting Caspase-Cleavable Linker.

Authors:  Seung Woo Chung; Jeong Uk Choi; Young Seok Cho; Ha Rin Kim; Tae Hyung Won; Peter Dimitrion; Ok-Cheol Jeon; Seong Who Kim; In-San Kim; Sang Yoon Kim; Youngro Byun
Journal:  Adv Sci (Weinh)       Date:  2018-06-05       Impact factor: 16.806

10.  Clinical trial protocol for TARDOX: a phase I study to investigate the feasibility of targeted release of lyso-thermosensitive liposomal doxorubicin (ThermoDox®) using focused ultrasound in patients with liver tumours.

Authors:  Paul C Lyon; Lucy F Griffiths; Jenni Lee; Daniel Chung; Robert Carlisle; Feng Wu; Mark R Middleton; Fergus V Gleeson; Constantin C Coussios
Journal:  J Ther Ultrasound       Date:  2017-11-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.